Abstract 69: Integrin αVβ3 targeted PET/CT for the assessment of bevacizumab therapy in patient-derived glioblastoma xenografts
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institutions: University of Copenhagen, Rigshospitalet
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409690631
